BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32157086)

  • 21. E6AP/UBE3A ubiquitin ligase harbors two E2~ubiquitin binding sites.
    Ronchi VP; Klein JM; Haas AL
    J Biol Chem; 2013 Apr; 288(15):10349-60. PubMed ID: 23439649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput assay exploiting disorder-to-order conformational switches: application to the proteasomal Rpn10:E6AP complex.
    Muli CS; Tarasov SG; Walters KJ
    Chem Sci; 2024 Mar; 15(11):4041-4053. PubMed ID: 38487241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity.
    Kumar S; Kao WH; Howley PM
    J Biol Chem; 1997 May; 272(21):13548-54. PubMed ID: 9153201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of ubiquitin chain synthesis employed by a HECT domain ubiquitin ligase.
    French ME; Klosowiak JL; Aslanian A; Reed SI; Yates JR; Hunter T
    J Biol Chem; 2017 Jun; 292(25):10398-10413. PubMed ID: 28461335
    [No Abstract]   [Full Text] [Related]  

  • 26. FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis.
    Rani N; Aichem A; Schmidtke G; Kreft SG; Groettrup M
    Nat Commun; 2012 Mar; 3():749. PubMed ID: 22434192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zn-binding AZUL domain of human ubiquitin protein ligase Ube3A.
    Lemak A; Yee A; Bezsonova I; Dhe-Paganon S; Arrowsmith CH
    J Biomol NMR; 2011 Sep; 51(1-2):185-90. PubMed ID: 21947926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade.
    Huang L; Kinnucan E; Wang G; Beaudenon S; Howley PM; Huibregtse JM; Pavletich NP
    Science; 1999 Nov; 286(5443):1321-6. PubMed ID: 10558980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity.
    Chan AL; Grossman T; Zuckerman V; Campigli Di Giammartino D; Moshel O; Scheffner M; Monahan B; Pilling P; Jiang YH; Haupt S; Schueler-Furman O; Haupt Y
    Biochemistry; 2013 May; 52(18):3119-29. PubMed ID: 23581475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E6AP/UBE3A catalyzes encephalomyocarditis virus 3C protease polyubiquitylation and promotes its concentration reduction in virus-infected cells.
    Carmody M; Notarianni TP; Sambel LA; Walsh SJ; Burke JM; Armstrong JL; Lawson TG
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):63-69. PubMed ID: 29054411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of E6AP/UBE3A-Mediated Protein Ubiquitination and Degradation Pathways by a Cyclic γ-AA Peptide.
    Huang B; Zhou L; Liu R; Wang L; Xue S; Shi Y; Jeong GH; Jeong IH; Li S; Yin J; Cai J
    J Med Chem; 2022 Feb; 65(3):2497-2506. PubMed ID: 35045253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the catalytic C-lobe of the HECT-type ubiquitin ligase E6AP.
    Ries LK; Liess AKL; Feiler CG; Spratt DE; Lowe ED; Lorenz S
    Protein Sci; 2020 Jun; 29(6):1550-1554. PubMed ID: 31994269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.
    Sparks A; Dayal S; Das J; Robertson P; Menendez S; Saville MK
    Oncogene; 2014 Sep; 33(38):4685-96. PubMed ID: 24121268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unstructured Biology of Proteins from Ubiquitin-Proteasome System: Roles in Cancer and Neurodegenerative Diseases.
    Gadhave K; Kumar P; Kapuganti SK; Uversky VN; Giri R
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32455657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation.
    Kapoor I; Kanaujiya J; Kumar Y; Thota JR; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
    Oncotarget; 2016 Feb; 7(7):7640-56. PubMed ID: 26506232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases.
    Canning P; Cooper CDO; Krojer T; Murray JW; Pike ACW; Chaikuad A; Keates T; Thangaratnarajah C; Hojzan V; Marsden BD; Gileadi O; Knapp S; von Delft F; Bullock AN
    J Biol Chem; 2013 Mar; 288(11):7803-7814. PubMed ID: 23349464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin proteasome system in immune regulation and therapeutics.
    Bhat SA; Vasi Z; Adhikari R; Gudur A; Ali A; Jiang L; Ferguson R; Liang D; Kuchay S
    Curr Opin Pharmacol; 2022 Dec; 67():102310. PubMed ID: 36288660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.
    Offensperger F; Müller F; Jansen J; Hammler D; Götz KH; Marx A; Sirois CL; Chamberlain SJ; Stengel F; Scheffner M
    Cell Chem Biol; 2020 Dec; 27(12):1510-1520.e6. PubMed ID: 32966807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
    Vats A; Trejo-Cerro O; Massimi P; Banks L
    J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.